Guillén J - Search Results

1

Development of ICT01, a first-in-class, anti-BTN3A antibody for activating Vγ9Vδ2 T cell-mediated antitumor immune response.

De Gassart A, Le KS, Brune P, Agaugué S, Sims J, Goubard A, Castellano R, Joalland N, Scotet E, Collette Y, Valentin E, Ghigo C, Pasero C, Colazet M, Guillén J, Cano CE, Marabelle A, De Bonno J, Hoet R, Truneh A, Olive D, Frohna P. De Gassart A, et al. Among authors: guillen j. Sci Transl Med. 2021 Oct 20;13(616):eabj0835. doi: 10.1126/scitranslmed.abj0835. Epub 2021 Oct 20. Sci Transl Med. 2021. PMID: 34669444

2

Effects of cicletanine in the left circumflex coronary artery occlusion-reperfusion canine model of sudden death: analysis of 107 experiments using Cox's proportional hazards model.

Jouve R, Puddu PE, Langlet F, Lanti M, Guillen JC, Rolland PH, Serradimigni A. Jouve R, et al. Among authors: guillen jc. Drugs Exp Clin Res. 1988;14(2-3):167-79. Drugs Exp Clin Res. 1988. PMID: 3416721

3

Different effects of epoprostenol on ischemia-induced ventricular arrhythmias in dogs.

Puddu PE, Langlet F, Lanti M, Guillen JC, Dawodu AA, Monti F, Schiariti M, Reale A. Puddu PE, et al. Among authors: guillen jc. Cardiologia. 1990 Jul;35(7):551-9. Cardiologia. 1990. PMID: 2088600

4

Cicletanide improves outcome after left circumflex coronary artery occlusion-reperfusion in the dog.

Jouve R, Langlet F, Puddu PE, Rolland PH, Guillen JC, Cano JP, Serradimigni A. Jouve R, et al. Among authors: guillen jc. J Cardiovasc Pharmacol. 1986 Jan-Feb;8(1):208-15. doi: 10.1097/00005344-198601000-00030. J Cardiovasc Pharmacol. 1986. PMID: 2419686

5

Prevention of postischaemic ventricular fibrillation by long term beta adrenoceptor blockade with acebutolol in the anaesthetised dog.

Puddu PE, Jouve R, Langlet F, Guillen JC, Fornaris M, Torresani J, Reale A. Puddu PE, et al. Among authors: guillen jc. Cardiovasc Res. 1986 Oct;20(10):721-6. doi: 10.1093/cvr/20.10.721. Cardiovasc Res. 1986. PMID: 2431780

6

Prevention of postischemic ventricular fibrillation late after right or left stellate ganglionectomy in dogs.

Puddu PE, Jouve R, Langlet F, Guillen JC, Lanti M, Reale A. Puddu PE, et al. Among authors: guillen jc. Circulation. 1988 Apr;77(4):935-46. doi: 10.1161/01.cir.77.4.935. Circulation. 1988. PMID: 3349588

7

[Correlation between delta R% and ST in standard electrocardiographic leads during acute myocardial ischemia in dogs].

Puddu PE, Jouve R, Lanti M, Langlet F, Guillen JC, Serradimigni A, Reale A. Puddu PE, et al. Among authors: guillen jc. Cardiologia. 1987 Jan;32(1):81-4. Cardiologia. 1987. PMID: 3581120 Italian. No abstract available.

8

Epoprostenol (PGI2) reduces the incidence of post-reperfusion ventricular fibrillation in the dog.

Jouve R, Puddu PE, Langlet F, Guillen JC, Serradimigni A. Jouve R, et al. Among authors: guillen jc. Cardiologia. 1985 Feb;30(2):91-7. Cardiologia. 1985. PMID: 3905005 No abstract available.

9

Molsidomine prevents post-ischaemic ventricular fibrillation in dogs.

Cano JP, Guillen JC, Jouve R, Langlet F, Puddu PE, Rolland PH, Serradimigni A. Cano JP, et al. Among authors: guillen jc. Br J Pharmacol. 1986 Aug;88(4):779-89. doi: 10.1111/j.1476-5381.1986.tb16250.x. Br J Pharmacol. 1986. PMID: 3755634 Free PMC article.

10

Epoprostenol (PGI2) prevents postischemic ventricular fibrillation and improves outcome in a canine model of sudden death.

Jouve R, Puddu PE, Langlet F, Guillen JC, Gautier T, Cano JP, Serradimigni A. Jouve R, et al. Among authors: guillen jc. J Pharmacol. 1985 Apr-Jun;16(2):139-57. J Pharmacol. 1985. PMID: 3903352

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

332 results

Search Page

Filters